|
|
|
Volumn 110, Issue 12, 2012, Pages 894-897
|
|
Ovarian cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
BEVACIZUMAB;
BLEOMYCIN;
CA 125 ANTIGEN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ETOPOSIDE;
GEMCITABINE;
IFOSFAMIDE;
MATRIX METALLOPROTEINASE INHIBITOR;
PACLITAXEL;
PLATINUM;
PROTEIN P53;
PROTEIN TYROSINE KINASE INHIBITOR;
TOPOTECAN;
TRABECTEDIN;
TUMOR VACCINE;
VALSPODAR;
ADJUVANT CHEMOTHERAPY;
ADVANCED CANCER;
ARTICLE;
ASCITES FLUID CYTOLOGY;
CANCER PROGNOSIS;
CANCER RECURRENCE;
CANCER STAGING;
COLOR ULTRASOUND FLOWMETRY;
COMPUTER ASSISTED TOMOGRAPHY;
EARLY CANCER;
FOLLOW UP;
GENE MUTATION;
GENE THERAPY;
GERM CELL TUMOR;
HISTOLOGY;
HUMAN;
INCIDENCE;
LAPAROTOMY;
METASTASIS;
OVARIECTOMY;
OVARY CANCER;
PELVIC EXAMINATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECURRENT CANCER;
SENSITIVITY AND SPECIFICITY;
SURVIVAL;
TRANSVAGINAL ECHOGRAPHY;
TUMOR CLASSIFICATION;
|
|
EID: 84872236050
PISSN: 00195847
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
